This is part of a continuing discussion now in progress, and may continue into an analysis covering the proteins, isoforms, enzyme catalysts, isoenzymes, substrate affinities, and signaling effects published in over 100 publications related to carcinogenesis and cell regulatory control of gluconeogenesis, glycolysis, and the ubiquitin pathway
Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?
June 21, 2014 by larryhbern
2 Responses
Leave a Reply
Follow Blog via Email
-
Recent Posts
- The Map of human proteins drawn by artificial intelligence and PROTAC (proteolysis targeting chimeras) Technology for Drug Discovery October 21, 2021
- Breakthrough Procedure in Aortic Valve Repair: VIDEO: How to Perform a Transcaval TAVR Procedure October 16, 2021
- Comparative Study: Four SARS-CoV-2 vaccines induce quantitatively different antibody responses against SARS-CoV-2 variants October 16, 2021
- A laboratory for the use of AI for drug development has been launched in collaboration with Pfizer, Teva, AstraZeneca, Mark and Amazon October 16, 2021
- Greylock Partners Announces Unique $500 Million Venture to act as Seed Capital Funding for Earliest Stage Startups October 16, 2021
- Technion students have developed a smart tool for predicting the risk of atrial fibrillation – a heart disorder that can lead to critical situations October 10, 2021
- Tweets and Re-Tweets of Tweets by @pharma_BI@AVIVA1950 at 2021 Virtual World Medical Innovation Forum, Mass General Brigham, Gene and Cell Therapy, VIRTUAL May 19–21, 2021 October 7, 2021
- The Nobel Prize in Chemistry 2021 October 6, 2021
- The Nobel Prize in Physiology or Medicine 2021 was awarded jointly to David Julius and Ardem Patapoutian “for their discoveries of receptors for temperature and touch.” October 4, 2021
- Tweets and Re-Tweets of Tweets by @pharma_BI @AVIVA1950 at EmTech MIT 2021 #EmTechMIT, 9/28 to 9/30/2021 October 4, 2021
Archives
Categories
Meta
-
2012pharmaceutical
-
Amandeep Kaur
-
Aashir Awan, Phd
-
Abhisar Anand
-
Adina Hazan
-
Alan F. Kaul, PharmD., MS, MBA, FCCP
-
alexcrystal6
-
anamikasarkar
-
apreconasia
-
aviralvatsa
-
David Orchard-Webb, PhD
-
danutdaagmailcom
-
Demet Sag, Ph.D., CRA, GCP
-
Daniel Menzin
-
Dror Nir
-
dsmolyar
-
Ethan Coomber
-
evelinacohn
-
Gail S Thornton
-
Irina Robu
-
jayzmit48
-
jdpmd
-
jshertok
-
kellyperlman
-
Ed Kislauskis
-
komal23ingle
-
larryhbern
-
Madison Davis
-
marzankhan
-
megbaker58
-
ofermar2020
-
Dr. Pati
-
pkandala
-
Rosalind Codrington, PhD
-
ritusaxena
-
Rick Mandahl
-
satwik Sunnam
-
sjwilliamspa
-
Srinivas Sriram
-
stuartlpbi
-
Dr. Sudipta Saha
-
tildabarliya
-
vaishnavee24
-
zraviv06
-
zs22
-
Larry is this an UPDATE to you famous article with same name?
If yes, then you need to go to the original paper on the Journal,
Write on top UPDATED on today date, bold red
Start to type NEW Content.
Thank you
The reader will have in same place everything you wished to publish on this topic.
This needs more time, and when Jose finishes with the World Cup, he’ll be sending me more. Then I can have a Part 1 and Part 2. I’ll have to get help from RR Coifman for the analysis, which might be impossible, but even in the Table I have only begun, it looks like the focus needs a new tool for chemotherapy. It hasn’t been unlocked – which I think, is the reason for so many failures.
On Sat, Jun 21, 2014 at 9:57 AM, Pharmaceutical Intelligence wrote:
>